Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Semaglutide”

580 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 580 results

Large-scale testing (Phase 3)Study completedNCT05040971
What this trial is testing

Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes

Who this might be right for
Obesity
Novo Nordisk A/S 207
Early research (Phase 1)Looking for participantsNCT07465965
What this trial is testing

A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

Who this might be right for
OverweightObesity
Shanghai World Leader Pharmaceutical Co., Ltd. 60
Not applicableNot Yet RecruitingNCT07152756
What this trial is testing

Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores

Who this might be right for
Gastric Retention
Fudan University 418
Testing effectiveness (Phase 2)Study completedNCT06131372
What this trial is testing

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

Who this might be right for
Chronic Kidney DiseaseType 2 DiabetesObesity
Novo Nordisk A/S 626
Large-scale testing (Phase 3)Not Yet RecruitingNCT07622810
What this trial is testing

BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity

Who this might be right for
Obesity & Overweight
Carnot Laboratories 352
Testing effectiveness (Phase 2)Study completedNCT02461589
What this trial is testing

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 706
Testing effectiveness (Phase 2)Study completedNCT06400615
What this trial is testing

Study That Tests AD109 in Patients Taking GLP-1 Drugs

Who this might be right for
OSA
Apnimed 40
Large-scale testing (Phase 3)Study completedNCT05890976
What this trial is testing

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)

Who this might be right for
OverweightObesity
Novo Nordisk A/S 200
Large-scale testing (Phase 3)Looking for participantsNCT06934655
What this trial is testing

Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in Youth

Who this might be right for
Pediatric ObesityMetabolic and Bariatric SurgerySemaglutide
Children's Hospital Los Angeles 150
Large-scale testing (Phase 3)Looking for participantsNCT07059377
What this trial is testing

Semaglutide for Smoking Cessation in Patients With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Nicotine AddictionTobacco Dependence
Ottawa Heart Institute Research Corporation 100
Not applicableStudy completedNCT04175665
What this trial is testing

Real-world Health Outcomes in Canadian Patients Using Semaglutide

Who this might be right for
Type 2 Diabetes
LMC Diabetes & Endocrinology Ltd. 1,133
Early research (Phase 1)Study completedNCT05429593
What this trial is testing

A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet

Who this might be right for
Healthy Volunteers
Novo Nordisk A/S 152
Post-approval studies (Phase 4)Study completedNCT04639414
What this trial is testing

Combined Active Treatment in Type 2 Diabetes With NASH

Who this might be right for
Type 2 DiabetesNon-alcoholic Steatohepatitis (NASH)Non-alcoholic Fatty Liver Disease (NAFLD)
German Diabetes Center 192
Large-scale testing (Phase 3)Study completedNCT02254291
What this trial is testing

A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 308
Large-scale testing (Phase 3)Study completedNCT03548935
What this trial is testing

STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

Who this might be right for
Metabolism and Nutrition DisorderOverweight or Obesity
Novo Nordisk A/S 1,961
Post-approval studies (Phase 4)Study completedNCT07732218
What this trial is testing

Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial

Who this might be right for
Type 2 Diabetes
Rehman Medical Institute - RMI 95
Post-approval studies (Phase 4)Study completedNCT05548647
What this trial is testing

Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects

Who this might be right for
Obesity
University of Pennsylvania 120
Testing effectiveness (Phase 2)Study completedNCT04216589
What this trial is testing

Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)

Who this might be right for
HIV InfectionsNon-Alcoholic Fatty Liver Disease
National Institute of Allergy and Infectious Diseases (NIAID) 51
Post-approval studies (Phase 4)Study completedNCT05857085
What this trial is testing

Novel Therapeutics and Endothelial Dysfunction in T1DM Patients

Who this might be right for
Endothelial DysfunctionDiabetes Mellitus, Type 1Biomarkers+7 more
General and Teaching Hospital Celje 90
Early research (Phase 1)Study completedNCT04109508
What this trial is testing

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets

Who this might be right for
Healthy VolunteersType 2 Diabetes
Novo Nordisk A/S 278
Next Page